• Trial Login
  • Trial Data Systems
  • Donate
  •            
NHMRC Clinical Trial Centre | Improving Health Outcomes NHMRC Clinical Trial Centre | Improving Health Outcomes NHMRC Clinical Trial Centre | Improving Health Outcomes
NHMRC Clinical Trial Centre | Improving Health Outcomes NHMRC Clinical Trial Centre | Improving Health Outcomes NHMRC Clinical Trial Centre | Improving Health Outcomes
×
  • About us
    • Who we are
    • Our People »
      • Management Committee
      • Academic Division Heads
      • Academics / Research Fellows
      • Senior Staff
      • Higher Degree Research Candidates
    • Global partners
    • Key stakeholders
    • Equity, diversity and inclusion
    • Support Us
    • Contact Us
  • Our research
      • RESEARCH AREAS

      • Biostatistics
      • Cancer
      • Cardiovascular
      • COVID-19
      • Diabetes
      • Evidence Integration
      • Health Economics
      • Kidney Health
      • Neonatal and Perinatal
      • Translational Research
      • Waratah Vaccine Trials Network
      • Respiratory
      • Specialist Areas

      • Australian New Zealand Clinical Trials Registry (ANZCTR)
      • Clinical Trial Research Development
      • Genomics Cancer Clinical Trials Initiative (GCCTI)
      • Health Technology Assessments
      • Independent Data Monitoring Committee
      • Labs
      • Novel Collaborations
      • Prognostic Tools for Clinicians
      • Randomisation Consult Trials
  • Our impact
    • Trial results
    • 30 years of impact
    • Case studies and examples
  • News & Events
    • CTC Talks: Learning webinar series
    • LIPID 20th anniversary
    • News »
      • Latest news
  • Publications
    • Annual reports
    • Published research
    • 30th anniversary book
    • Sharing our Research Data
  • Careers & Education
    • Working at the CTC »
      • Featured Vacancies
      • Professional roles at CTC
      • Summer Research Program 2023/2024
    • Learning with the CTC »
      • Educating the next generation
    • Innovation in trials program
  • Patients
    • Patient engagement
    • Why participate in a clinical trial?
    • What is a Clinical Trial?

Password Recovery

To recover your password please fill in your email address

Back To Login
Don't Have An Account Yet ? Signup!

Create An Account

Please fill in below form to create an account with us

Back To Login

Member Login

Forgot Your Password ?
Don't Have An Account Yet ? Signup!

Gastro-Intestinal Cancer

Quick Links

  • Support Us
  • Contact Us
  • Our People

Research Areas

  • Oncology
  • Cardiovascular
  • COVID-19
  • Diabetes
  • Kidney Health
  • Neonatal
  • Health Economics
  • Biostatistics
  • Evidence Integration
  • Translational research

The CTC has collaborated with the Australian Gastro-Intestinal Trials Group (AGITG) since 1991 to conduct clinical trials to improve treatments for gastro‑intestinal cancers.

Together we have completed over 57 trials involving more than 5,000 patients. Our research has changed treatment practices and improved patient life expectancy and quality of life.

 

 

Gastro- Intestinal Cancer

  • Open Trials
  • In Follow Up
  • Completed
COLORECTAL CANCER (ASCOLT)
resectable gastric cancer (TOPGEAR)
Pancreatic Cancer (MASTERPLAN)
Colon Cancer (RoLaCaRT-1)
Colorectal Cancer (SPAR)
GIST (SSGXXII)
PANCREATIC CANCER (ASCEND)
Cancer of the Rectum (A La CaRT)
PANCREATIC AND MIDGUT TUMOURS (CONTROL NETS) - Pre-Activation
Colorectal Cancer (liberate)
Stomach cancer (INTEGRATE II)
metastatic pancreatic cancer (IMPACT)
G13D Mutation (ICECREAM)
gastrointestinal stromal tumours (GIST)
gastrointestinal stromal tumours (Advanced GIST)
pretreated advanced colorectal carcinoma (CO.23)
Resectable pancreas cancer (GAP)
hepatic metastases from colorectal cancer (ATTACHE)
locally advanced rectal cancer (PETACC6)
resectable gastric cancer (TACTIC)
short course oncology therapy (SCOT)
Oesophagus Cancer (DOCTOR)
Inoperable Locally Recurrent or Metastatic Disease (InterAACT)
Cancer of the BILIARY TRACT (ACTICCA-1)
Colorectal Cancer (MONARCC)
Gastrointestinal Neuroendocrine Carcinomas (NABNEC)
gastrointestinal stromal tumours (ALT GIST)

NHMRC Clinical Trials Centre at the University of Sydney

ABN 15 211 513 464 CRICOS number: 00026A

  •    +61 2 9562 5000
  •    +61 2 9565 1863
  •    ctc.enquiry@sydney.edu.au
  •            
  • About Us
  • Our Work
  • Our Impact
  • News & Events
  • Careers & Education
  • FAQ
  • Contact Us

2019 © NHMRC Clinical Trials Centre at the University of Sydney. All Rights Reserved.

We acknowledge the traditional custodians of the lands on which we work and live, and pay our respects to Elders past, present and future.


Disclaimer    Privacy

Smiley face